Prognostic impact of high-risk factors and KRAS mutation in patients with stage II deficient mismatch repair colon cancer: a retrospective cohort study
Yuting Zhang(Shenzhen University), Yanhong Deng(Sun Yat-sen University), Yabing Cao(Xi'an Polytechnic University), Miaomiao Ding(Sun Yat-sen University), Jianwei Zhang(Shanxi Academy of Medical Sciences), Bin Zhang(King Abdullah University of Science and Technology), Yi Chen(Sichuan University of Arts and Science), Huabin Hu(Sun Yat-sen University), Zehua Wu(Shanghai Jiao Tong University)
Cited by 10
Related Papers
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
|Nature|2017|402